Active PriorityDeveloping
Nexentis Partners with Boltz AI to Advance Drug Discovery through Innovative Target Screening
worth trackingUpdated 2h ago
Key takeaway: The partnership represents a significant step towards enhancing drug discovery processes using AI-driven methodologies.